retatrutide phase 2 trial type 2 diabetes results 2024 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Phase III retatrutide study demonstrates

Roles of Thioredoxin and Thioredoxin Reductase in the Resistance to Oxidative Stress in Lactobacillus casei . Microbiology 158, no

Suitable for practitioner-guided and lifestyle-based supplementation plans

Lack of Sleep: Chronic fatigue puts a significant strain on the cardiovascular system

These findings collectively indicate that modulation of the gut microbiotaSCFAGPR axis plays a pivotal role in alleviating DN-associated renal fibrosis, supporting its potential as a microbiota-targeted therapeutic strategy for improving renal outcomes in DN

One way to interpret this figure is to select a change in body weight of interest on the horizontal axis and note the corresponding proportions of patients (vertical axis) in each treatment group who achieved at least that degree of weight loss